default author photo

Michiaki Kubo

RIKEN Center for Integrative Medical Sciences

1-7-22, Suehiro-cho

Tsurumi-ku

Yokohama, Kanagawa

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

235

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase 2 Study

Number of pages: 35 Posted: 06 Apr 2019
National Cancer Center Hospital - Department of Breast and Medical Oncology, Keio University - Department of Clinical Pharmacokinetics and Pharmacodynamics, Toranomon Hospital - Department of Medical Oncology, Fukushima Medical University, Yokohama City University, National Cancer Center Hospital - Department of Breast and Medical Oncology, National Hospital Organization Hokkaido Cancer Center - Department of Breast Surgery, Showa University - Advanced Cancer Translational Research Institute, Kumamoto Shinto General Hospital, Tokyo-West Tokushukai Hospital, Seirei Sakura Citizen Hospital, University of Texas at Houston - MD Anderson Cancer Center, RIKEN Center for Integrative Medical Sciences, RIKEN Center for Integrative Medical Sciences, National Cancer Center Hospital - Department of Breast and Medical Oncology and Keio University - Department of Clinical Pharmacokinetics and Pharmacodynamics
Downloads 147 (502,974)

Abstract:

Loading...

breast cancer, CYP2D6, endoxifen, genotype-guided dosing, tamoxifen

2.

Genome-Wide Meta-Analysis Identifies the Organic Anion-Transporting Polypeptide Gene SLCO1B1 and Statins as Modifiers of Glycemic Response to Sulfonylureas

Number of pages: 23 Posted: 09 Mar 2021
University of Dundee - Division of Population Health and Genomics, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, University of Dundee - Division of Population Health and Genomics, Leiden University - Department of Cell and Chemical Biology, Genomic Medicine Institute, University of Dundee - Division of Population Health and Genomics, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Eshelman School of Pharmacy, Kaiser Permanente Northern California Division of Research, Harvard University - Massachusetts General Hospital, VU University Amsterdam - Amsterdam Public Health Research Institute, VU University Amsterdam - Amsterdam Public Health Research Institute, Leiden University - Department of Cell and Chemical Biology, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, Genomic Medicine Institute, Geisinger, RIKEN Center for Integrative Medical Sciences, RIKEN Center for Integrative Medical Sciences, RIKEN Center for Integrative Medical Sciences, University of Dundee - Division of Population Health and Genomics, Harvard University - Massachusetts General Hospital, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, Leiden University - Department of Cell and Chemical Biology, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences and University of Dundee - Division of Population Health and Genomics
Downloads 88 (753,595)

Abstract:

Loading...